Valuation: Merck KGaA

Capitalization 47.89B 55.54B 43.23B 41.48B 75.64B 5,105B 79.16B 511B 205B 2,448B 208B 204B 8,755B P/E ratio 2026 *
17.2x
P/E ratio 2027 * 15x
Enterprise value 53.8B 62.4B 48.57B 46.6B 84.98B 5,735B 88.93B 574B 230B 2,750B 234B 229B 9,836B EV / Sales 2026 *
2.55x
EV / Sales 2027 * 2.36x
Free-Float
29.72%
Yield 2026 *
2.16%
Yield 2027 * 2.27%
1 day-2.69%
1 week-14.15%
Current month-14.15%
1 month-9.30%
3 months-8.70%
6 months+0.55%
Current year-10.15%
1 week 109.7
Extreme 109.7
126.5
1 month 109.7
Extreme 109.7
129.3
Current year 109.7
Extreme 109.7
131.65
1 year 100.7
Extreme 100.7
137.45
3 years 100.7
Extreme 100.7
177.35
5 years 100.7
Extreme 100.7
231.5
10 years 71.15
Extreme 71.15
231.5
Manager TitleAgeSince
Chief Executive Officer 64 2021-04-30
Director of Finance/CFO 55 2023-06-30
Chief Tech/Sci/R&D Officer - 2021-06-30
Director TitleAgeSince
Director/Board Member - 2019-04-25
Director/Board Member 63 2012-04-30
Director/Board Member 77 2014-05-08
Change 5d. change 1-year change 3-years change Capi.($)
-2.69%-14.15%-22.05%-38.12% 55.54B
+0.01%-3.11%+12.00%+48.13% 7.95B
+4.04%-21.96%+3.92%-21.30% 7.48B
-3.47%-14.11%-10.68%+57.34% 5.43B
+0.51%-9.89%-20.43%+96.73% 4.97B
-0.74%-1.57%+69.30%+40.36% 3.1B
+4.04%-4.33%-17.86%-22.27% 2.68B
-2.72%-11.59%+314.93%+718.18% 2.56B
+1.59%-2.38%+40.41%+58.44% 2.54B
+2.85%+1.31%-3.82%+4.54% 2.11B
Average +0.34%-7.06%+36.57%+94.20% 9.44B
Weighted average by Cap. -1.31%-9.50%-2.03%+10.16%

Financials

2026 *2027 *
Net sales 21.07B 24.44B 19.02B 18.25B 33.28B 2,246B 34.83B 225B 90.09B 1,077B 91.73B 89.78B 3,852B 22.08B 25.61B 19.93B 19.13B 34.88B 2,354B 36.5B 236B 94.41B 1,129B 96.13B 94.08B 4,037B
Net income 2.74B 3.17B 2.47B 2.37B 4.32B 292B 4.52B 29.19B 11.69B 140B 11.91B 11.65B 500B 3.16B 3.66B 2.85B 2.74B 4.99B 337B 5.22B 33.7B 13.5B 161B 13.75B 13.45B 577B
Net Debt 5.91B 6.86B 5.34B 5.12B 9.34B 630B 9.77B 63.09B 25.27B 302B 25.73B 25.19B 1,081B 4.12B 4.78B 3.72B 3.57B 6.51B 440B 6.82B 44.02B 17.63B 211B 17.95B 17.57B 754B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.1%); - pharmaceutical products (40%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.9%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.7%), Switzerland (1.9%), Europe (22.6%), the United States (25.7%), North America (1.3%), China (13.5%), Asia/Pacific (19.6%), Latin America (7%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
26-03-06 110.15 -2.69% 737,000
26-03-05 113.20 -8.00% 979,576
26-03-04 123.05 +1.40% 383,159
26-03-03 121.35 -3.88% 351,330
26-03-02 126.25 -1.60% 251,095
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
110.15EUR
Average target price
150.44EUR
Spread / Average Target
+36.58%

Quarterly revenue - Rate of surprise